Prof Evan Reid
Evan Reid graduated in Medicine at Glasgow University in 1991, then trained in Medical Genetics in Glasgow and Cambridge.
He became interested in the hereditary spastic paraplegias (HSPs), genetic forms of motor neuron degeneration and completed a PhD on the genetics of these conditions, supervised by David Rubinsztein, in 2000.
His research has encompassed the clinical features, genetics and cell biology of HSPs, but now concentrates on the functions of the microtubule severing enzyme spastin at membrane traffic pathways.
Between 2004 and 2014 he was a Wellcome Trust Advanced then Senior Fellow, and in 2014 was appointed to a University Lecturer position at the University of Cambridge.
His research group has been based in Cambridge Institute for Medical Research since 2004. He is clinically active and runs a specialised neurogenetics clinic at Addenbrooke's Hospital.
Dr Michael Buckland
Assoc Prof. Michael Buckland is head of Neuropathology at Royal Prince Alfred Hospital and an Honorary Associate at the University of Sydney.
Michael’s particular research interests are Gliomas, Epigenetics, Neuroinflammatory and Neurodegenerative diseases.
Genetics has revolutionised the classification of gliomas and other CNS tumours resulting in a major revision of the WHO classification of CNS tumours in late 2016. Michael has been investigating the proteins that promote invasion and spread of glioblastoma and has a unique insight into these mechanisms and their prognostic value.
Michael has also been researching the role that exosomes have in multiple sclerosis. These microvesicles are secreted from the cell and contain unique proteins which are specifically involved in the pathogenesis of the disease.